Vir Biotechnology (VIR)
(Real Time Quote from BATS)
$10.92 USD
-0.31 (-2.76%)
Updated Jun 10, 2024 11:04 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Vir Biotechnology, Inc. [VIR]
Reports for Purchase
Showing records 41 - 50 ( 50 total )
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Best-in-Class Attributes of SARS-CoV-2 Antibodies on Display With Lilly Collaboration; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Potential Best-in-Class HBV Program Clears Another Hurdle, Generates Positive Read Through to COVID-19 Program
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Now You See me, Now You Don''t; Sneaky SARS-CoV-2 Variants May Not Escape From VIR-7831; Upping PT to $125
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
3Q20 Results; Infectious Disease Pipeline Advancing; SARS-CoV-2 mAb Pivotal Trial Data Expected in January
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Read Through From Regeneron''s Initial Data Cut on COVID-19 Antibody Cocktail to Vir''s COVID-19 Program
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Maintains Leading Position in COVID-19 mAb Race; Upping Price Target to $80
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Biopharma''s Next $100B-Plus Global Market: Cures for Chronic Hepatitis B Virus Infection
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Vir Biotechnology, Inc.
Industry: Medical - Biomedical and Genetics
Voltron of Immunology; Initiating Coverage With a Buy and $75 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department